Atlas Trials

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT02420795 · TERMINATED

Trial details

NCT number
NCT02420795
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell LymphomaRecurrent Non-Hodgkin LymphomaRefractory Mantle Cell LymphomaRefractory Non-Hodgkin LymphomaSplenic Mantle Cell Lymphoma
Start date
2015-11-03
Primary completion
2020-11-16
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.